[1] |
Javitt DC,Sweet RA.Auditory dysfunction in schizophrenia:integrating clinical and basic features[J].Nat Rev Neurosci,2015,16(9):535-550.
|
[2] |
管丽丽,杜立哲,马弘.精神分裂症的疾病负担(综述)[J].中国心理卫生杂志,2012,26(12):913-919.
|
[3] |
Alizadeh F,Tavakkoly-Bazzaz J,Bozorgmehr A,et al.Association of transcription factor 4 (TCF4) gene mRNA level with schizophrenia, its psychopathology, intelligence and cognitive impairments[J].J Neurogent,2017,31(4):344-351.
|
[4] |
Yolken RH,Torrey EF.Are some cases of psychosis caused by microbial agents:a review of the evidence[J].Mol Psychiatry,2008,13(5):470-479.
|
[5] |
高可润,禹顺英.精神分裂症的感染与免疫学研究进展[J].中国神经精神疾病杂志,2011,37(9):574-576.
|
[6] |
林举达.精神分裂症的一种新理论:脑外慢性隐性细菌性感染致中毒性脑病[J].医药前沿,2016, 6(18):171-172.
|
[7] |
林举达,颜海锋,林志雄,等.抗感染治愈急性分裂样精神障碍 2 例[J].医学理论与实践,2015,28(24):3347-3348.
|
[8] |
林举达,殷静雯,颜海锋,等.抗感染治愈精神分裂症1例报告分析[J].医药前沿,2015, 5(28):140-141.
|
[9] |
林举达,罗旭东,林志雄,等.抗感染治愈精神分裂症3例[J].广东医学院学报,2014,32(4):590-591.
|
[10] |
Fuglewicz AJ,Piotro wski P,Stodolak A.Relationship between toxoplasmosis and schizophrenia:a review[J].Adv Clin Exp Med,2017, 26(6):1033-1038.
|
[11] |
Berenreiterová M,Flegr J,Kuběna AA,et al.The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis:implications for the behavioral manipulation hypothesis[J].PLoS One,2011,6(12):e28925.
|
[19] |
Yolken RH,Torrey EF.Viruses,schizophrenia,and bipolar disorder[J].Clin Microbiol Rev,1995,8(1):131-145
|
[20] |
Brown AS,Begg MD,Gravenstein S,et al.Serologic evidence of prenatal influenza in the etiology of schizophrenia[J].Arch Gen Psychiat.2004,60(1):774-780.
|
[24] |
杨全凤,徐平.博尔纳病病毒的研究进展[J].临床合理用药杂志,2015,8(21):165-166.
|
[26] |
姚能云,佘艳梅,周红勤,等.博尔纳病病毒感染与精神分裂症关系的初步研究[J].临床精神医学杂志,2014,24(5):315-319.
|
[12] |
Yolken R,Torrey EF,Dickerson F.Evidence of increased exposure to Toxoplasma gondiiin individuals with recent onset psychosis but not with established schizophrenia[J].PLoS Neglect Trop D,2017,11(11):e0006040.
|
[13] |
Abdollahian E,Shafiei R,Mokhber N,et al.Seroepidemiological study of toxoplasma gondii infection among psychiatric patients in mashhad,northeast of Iran[J].Iran J Parasitol,2017,12(1):117-122.
|
[14] |
Torrey E,Bartko JJ,Lun ZR,et al.Antibodies to toxoplasma gondii in patients with schizophrenia:a meta-analysis[J].Schizophrenia Bull,2007,3(3):729-736.
|
[15] |
Sutterland AL.Beyond the association.Toxoplasma gondii in schizophrenia bipolar disorder,and addiction:systematic review and meta-analysis[J].Acta Psychiat Scand,2015,32(3):161-179.
|
[16] |
Fond G,Capdevielle D,Macgregor A,et al.oxoplasma gondii:a potential role in the genesis of psychiatric disorders[J].Encephale,2013,39(1):38-43.
|
[17] |
Tedford E,Mcconkey G.Neurophysiological changes induced by chronic Toxoplasma gondii infection[J].Pathogens,2017,6(2):19.
|
[18] |
Halonen SK.Use of human neurons derived via cellular reprogramming methods to study host-parasite interactions of toxoplasma gondii in Neurons[J].Cells,2017, 6(4):32.
|
[21] |
Selten JP,Termorshuizen F.The serological evidence for maternal influenza as risk factor for psychosis in offspring is insufficient:critical review and meta-analysis[J].Schizophr Res,2016,183:2-9.
|
[22] |
Buka SL,Tsuang MT,Torrey EL,et al.Maternal infections and subsequent psychosis among offspring[J].Rich Gen Psychiatry,2001,58(11):1032-1037.
|
[23] |
Blomstrom A,Karlsson H,Wicks S,et al.Maternal antibodies to infectious agents and risk for non-affective psychoses intheoffspring——amatched case-control study[J].Schizophr Res,2012,140(1-3):25-30.
|
[25] |
Mazaheritehrani E,Maghsoudi N,Shams J,et al.Borna diseasevirus(BDV)infectioninpsychiatricpatientsandhealthy controls in Iran[J].Virol J,2014,11(1):161.
|
[27] |
Na KS,Tae SH,Song JW,et al.Failure to detect borna disease virus antibody and RNA from peripheral blood mononuclear cells of psychiatric patients[J].Psychiat Invest,2009,6(4):306-312.
|
[28] |
Bauerstaeb C,Jorgensen L,Lewis G,et al.Prevalence and risk factors for HIV,hepatitis B,and hepatitis C in people with severe mental illness:a total population study of Sweden[J].Lancet Psychiat,2017,4(9):685-693.
|
[29] |
Khandaker GM,Stochi J,Zammit S,et al.Khandaker.Childhood Epstein-Barr Virus infection and subsequent risk of psychotic experiences in adolescence:a population-based prospective serological study[J].Schizophr Res,2014,58(1-3):19-24.
|
[30] |
Brown AS,Derkits EJ.Prenatal infection and schizophrenia:a review of epidemiologic and translational studies[J].Am J Psychiatry, 2010,167(3):261-280.
|
[31] |
律东,林举达,李明颖,等.79例精神分裂症患者血液内毒素分析[J].齐齐哈尔医学院学报,2016 37(24):3000-3002.
|
[32] |
林举达,律东,麦奇,等.精神分裂症患者血液及脑脊液LPS 阳性 1 例[J].医药前沿,2017,7(22):100.
|
[33] |
Benros Michael E,Nielsen Philip R,Nordentoft Merete,et al.Autoimmune diseases and severe infections as risk factors for schizophrenia:a 30-year population-based register study[J].Am J Psychiat,2011,168(12):1303-1310.
|
[34] |
戴准,杨志江,罗旭东,等.精神分裂症合并血清胆红素轻度增高 5 例[J].医药前沿,2017,(23):377-378.
|
[35] |
律东,冼君定,林志雄,等.精神分裂症与隐性感染的相关性[J].神经疾病与精神卫生,2015,15(5):500-502.
|
[36] |
律东,冼君定,谢博,等.血液白细胞分析在青中年精神分裂症患者中的临床意义[J].中国当代医药,2016,23(12):39-41.
|
[37] |
Wang Z,Li P,Chi D,et al.Association between C-reactive protein and risk of schizophrenia:an updated meta-analysis[J].Oncotarget,2017,(43):75445-75454.
|
[38] |
Inoshita M,Numata S,Tajima A,et al.A significant causal associationbetweenC-reactiveproteinlevelsandschizophrenia[J].Sci Rep, 2016,6:46947.
|
[39] |
鲜凌瑾,唐勇.肠道细菌微生态与人类疾病关系研究进展[J].微生物学免疫学进展,2015,43(4):75-79.
|
[40] |
黄坤,吴丽丽,杨云生.肠道微生态与人类疾病关系的研究进展[J].传染病信息,2017,30(3):133-137.
|
[41] |
邵红敏,张玖龙肠道菌群与精神分裂症[J].神经疾病与精神卫生,2016,16(3):368-370.
|
[42] |
Najjar S,Pahlajani S,Sanctis VD,et al.Neurovascular unit dysfunction and blood-brain barrier hyperpermeability Contribute to Schizophrenia Neurobiology:a theoretical integration of clinical and experimental evidence[J].Front Psychiatry,2017,8:83.
|
[43] |
Braniste V,Alasmakh M,Kowal C,et al.The gut microbiota influences blood-brain barrier permeability in mice[J].Sci Transl Med, 2014, 6(263):263ra158.
|
[44] |
Adams DD,Knight JG,Ebringer A.The autoimmune model of schizophrenia[J].Isrn Psychiatry,2012,2012(13):758072.
|
[45] |
Miller BJ,Buckley P,Seabolt W,et al.Meta-analysis of cytokine alterations in schizophrenia:clinical sTATUS and antipsychotic effects[J].Biol Psychiat,2011,70(7):663-671.
|
[46] |
Fineberg AM,Ellman LM.Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia[J].Biol Psychiat,2013,73(10):951-966.
|